http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EE-200000617-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1999-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2f5e98793eb73827e388dce7632c090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c37cf4c718945f23dbaf91a883483b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c590de30d4fdebb2fb9381d7cb9107ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf8d3ea1c74f1a5570c76904fe72b22
publicationDate 2002-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EE-200000617-A
titleOfInvention Controlled release oral formulations of levosimendan
priorityDate 1998-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502430

Total number of triples: 25.